Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas

Virology Journal

Volumn 9, Issue , 2012, Pages

  Wang, Xinying ^a   Wang, Yun ^a   Wu, Guocai ^a   Chao, Yan ^c   Sun, Zhifu ^b   Luo, Bing ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b MAYO CLINIC   (United States)

^c GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

Epstein Barr virus; Gastric carcinoma; Nasopharyngeal carcinoma; Nuclear antigen 2; Polymorphism

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; EBNA 2 PROTEIN, HUMAN HERPESVIRUS 4; EBNA-2 PROTEIN, HUMAN HERPESVIRUS 4; EPSTEIN BARR VIRUS ANTIGEN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE DELETION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; NASOPHARYNX CARCINOMA; STOMACH CARCINOMA; AMINO ACID SUBSTITUTION; CARCINOMA; CHEMISTRY; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETICS; MOLECULAR GENETICS; MUTATION; NASOPHARYNX TUMOR; PROTEIN TERTIARY STRUCTURE; STOMACH TUMOR; VIROLOGY;

HUMAN HERPESVIRUS 4;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CARCINOMA; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; VIRAL PROTEINS;

EID: 84862826204     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-49     Document Type: Article

References (34)

1. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB, J Gen Virol 1994 75 Pt 1 95 100 8113744 (Pubitemid 24033984)
2. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, Henle W, Nature 1978 274 756 761 10.1038/274756a0 210392 (Pubitemid 8406152)
3. Cellular target genes of Epstein-Barr virus nuclear antigen 2. Maier S, Staffler G, Hartmann A, Hock J, Henning K, Grabusic K, Mailhammer R, Hoffmann R, Wilmanns M, Lang R, et al. J Virol 2006 80 9761 9771 10.1128/JVI.00665-06 16973580 (Pubitemid 44435650)
4. Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. Tsui S, Schubach WH, J Virol 1994 68 4287 4294 8207803 (Pubitemid 24183021)
5. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Griffin BE, Rev Med Virol 1998 8 61 66 10.1002/(SICI)1099- 1654(199804/06)8:2<61::AID-RMV215>3.0.CO;2-H 10398495 (Pubitemid 128756777)
6. Epstein-Barr virus and gastric carcinoma - viral carcinogenesis through epigenetic mechanisms. Uozaki H, Fukayama M, Int J Clin Exp Pathol 2008 1 198 216 18784828
7. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS, J Gastroenterol Hepatol 2009 24 354 365 10.1111/j.1440-1746. 2009.05775.x 19335785
8. Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas. Jia Y, Wang Y, Chao Y, Jing Y, Sun Z, Luo B, Virol J 2010 7 341 21106109
9. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. Ling PD, Ryon JJ, Hayward SD, J Virol 1993 67 2990 3003 8388484 (Pubitemid 23143666)
10. Early events in Epstein-Barr virus infection of human B lymphocytes. Alfieri C, Birkenbach M, Kieff E, Virology 1991 181 595 608 10.1016/0042- 6822(91)90893-G 1849678
11. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. Allday MJ, Crawford DH, Griffin BE, J Gen Virol 1989 70 Pt 7 1755 1764 2544663 (Pubitemid 19170211)
12. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. Rooney C, Howe JG, Speck SH, Miller G, J Virol 1989 63 1531 1539 2538644 (Pubitemid 19085965)
13. Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. Grasser FA, Haiss P, Gottel S, Mueller-Lantzsch N, J Virol 1991 65 3779 3788 1645792
14. BAMHI DNA fragment H-polymorphism of Epstein-Barr virus is associated with the mutations present in an 89 BP sequence localized in EBNA2 gene. Sheng W, Bouguermouh A, Bouzid M, Djennaoui D, Ooka T, Virus Genes 2004 29 99 108 15215688 (Pubitemid 38903596)
15. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Cohen JI, Wang F, Kieff E, J Virol 1991 65 2545 2554 1850028
16. Four EBNA2 domains are important for EBNALP coactivation. Peng CW, Zhao B, Kieff E, J Virol 2004 78 11439 11442 10.1128/JVI.78.20.11439-11442.2004 15452270 (Pubitemid 39299690)
17. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator. Cohen JI, Kieff E, J Virol 1991 65 5880 5885 1656076
18. Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. Chao Y, Jing Y, Jia Y, Wang Y, Zhao C, Luo B, J Med Virol 2011 83 644 650 10.1002/jmv.22091 21328379
19. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Bornkamm GW, Int J Cancer 2009 124 1745 1755 10.1002/ijc.24223 19165855
20. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Niedobitek G, Mol Pathol 2000 53 248 254 10.1136/mp.53.5.248 11091848
21. Epstein-Barr virus and cancer. Thompson MP, Kurzrock R, Clin Cancer Res 2004 10 803 821 10.1158/1078-0432.CCR-0670-3 14871955 (Pubitemid 38198878)
22. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma. Wang Y, Luo B, Yan LP, Huang BH, Zhao P, World J Gastroenterol 2005 11 3234 3239 15929173 (Pubitemid 40973891)
23. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, J Virol 1990 64 4084 4092 2166806 (Pubitemid 20279813)
24. Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea. Shim YS, Kim CW, Lee WK, Mol Cells 1998 8 226 232 9638656
25. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan. Higa M, Kinjo T, Kamiyama K, Iwamasa T, Hamada T, Iyama K, J Clin Pathol 2002 55 414 423 10.1136/jcp.55.6.414 12037022 (Pubitemid 34620777)
26. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. Midgley RS, Bell AI, McGeoch DJ, Rickinson AB, J Virol 2003 77 11517 11530 10.1128/JVI.77.21.11517-11530.2003 14557637 (Pubitemid 37271650)
27. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. Walling DM, Perkins AG, Webster-Cyriaque J, Resnick L, Raab-Traub N, J Virol 1994 68 7918 7926 7966582 (Pubitemid 24362679)
28. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I, Zeng YX, J Virol 2005 79 15323 15330 10.1128/JVI.79.24.15323-15330.2005 16306603 (Pubitemid 43032314)
29. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K, Virus Res 2009 143 209 221 10.1016/j.virusres.2009.07. 005 19596032
30. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates. Wang X, Liu X, Jia Y, Chao Y, Xing X, Wang Y, Luo B, J Gen Virol 2010 91 2564 2573 10.1099/vir.0.021881-0 20554797
31. New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China. Wang Y, Zhang X, Chao Y, Jia Y, Xing X, Luo B, J Med Virol 2010 82 829 836 10.1002/jmv.21714 20336720
32. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. Ling PD, Hayward SD, J Virol 1995 69 1944 1950 7853539
33. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T, Br J Cancer 1996 74 625 631 10.1038/bjc.1996.412 8761381 (Pubitemid 26279061)
34. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T, Microbes Infect 2000 2 115 120 10.1016/S1286-4579(00)00277-X 10742683 (Pubitemid 30154700)